Open Access
Erratum
Issue
BioMedicine
Volume 7, Number 2, June 2017
Article Number 13
Number of page(s) 8
DOI https://doi.org/10.1051/bmdcn/2017070207
Published online 14 June 2017
  1. Song Z, McClain CJ, Chen T. S-adenosylmethionine protects against acetaminophen-induced hepatotoxicity in mice. Pharmacology 2004; 71: 199–208. [CrossRef] [PubMed] [Google Scholar]
  2. Masubuchi Y, Suda C, Horie T. Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 2005; 42: 110–6. [PubMed] [Google Scholar]
  3. Oz HZ, McClain CJ, Nagasawa HT, Ray MB, de Villiers WJ, Chen TS. Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Molecular Toxicol 2004; 18: 361–8. [CrossRef] [Google Scholar]
  4. Coen M. Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity. Drug Metab Rev 2015; 47: 29–44. [CrossRef] [PubMed] [Google Scholar]
  5. Hsu CC, Lin CC, Liao TS, Yin MC. Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice. Food Chem Toxicol 2006; 44: 393–7. [CrossRef] [PubMed] [Google Scholar]
  6. Yan SL, Wu ST, Yin MC, Chen HT, Chen HC. Protective effects from carnosine and histidine on acetaminophen-induced liver injury. J Food Sci 2009; 74: 259–65. [Google Scholar]
  7. Zager RA, Johnson AC, Lund S, Randolph-Habecker J. Toll like receptor (TLR4) shedding and depletion: acute proximal tubular cell responses to hypoxic and toxic injury. Am J Physiol Renal Physiol 2007; 292: 304–12. [Google Scholar]
  8. Salama M, Elgamal M, Abdelaziz A, Ellithy M, Magdy D, Ali L, et al. Toll-like receptor 4 blocker as potential therapy for acetaminophen-induced organ failure in mice. Exp Ther Med 2015; 10: 241–6. [CrossRef] [PubMed] [Google Scholar]
  9. Cavassani KA, Moreira AP, Habiel D, Ito T, Coelho AL, Allen RM, et al. Toll like receptor 3 plays a critical role in the progression, severity of acetaminophen-induced hepatotoxicity PLoS One 2013; 8: e65899. [PubMed] [Google Scholar]
  10. Frank A, Unger M. Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction. J Chromatogr A 2006; 1112: 255–62. [PubMed] [Google Scholar]
  11. Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med 2006; 72: 1100–16. [CrossRef] [PubMed] [Google Scholar]
  12. Gayathri B, Manjula N, Vinaykumar KS, Lakshmi BS, Balakrishnan A. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNFalpha, IL-1beta, NO and MAP kinases. Int Immunopharmacol 2007; 7: 473–82. [CrossRef] [PubMed] [Google Scholar]
  13. Yin MC, Lin MC, Mong MC, Lin CY. Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice. J Agric Food Chem 2012; 60: 7697–701. [CrossRef] [PubMed] [Google Scholar]
  14. Lozano-Mena G, Juan ME, Garcia-Granados A, Planas JM. Determination of maslinic acid, a pentacyclic triterpene from olives, in rat plasma by high-performance liquid chromatography. J Agric Food Chem 2012; 60: 10220–5. [CrossRef] [PubMed] [Google Scholar]
  15. Westin J, Lagging LM, Wejstal R, Norkrans G, Dhillon AP. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999; 19: 183–7. [PubMed] [Google Scholar]
  16. Liu ZX, Kaplowitz N. Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2006; 2: 493–503. [CrossRef] [PubMed] [Google Scholar]
  17. Farombi EO, Surh YJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 2006; 39: 479–91. [PubMed] [Google Scholar]
  18. Noh JR, Kim YH, Hwang JH, Choi DH, Kim KS, Oh WK, et al. Sulforaphane protects against acetaminophen-induced hepatotoxicity. Food Chem Toxicol 2015; 80: 193–200. [CrossRef] [PubMed] [Google Scholar]
  19. Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 2000; 67: 275–82. [CrossRef] [PubMed] [Google Scholar]
  20. Hazai E, Vereczkey L, Monostory K. Reduction of toxic metabolite formation of acetaminophen. Biochem Biophys Res Commun 2002; 291: 1089–94. [PubMed] [Google Scholar]
  21. Yamaura K, Shimada M, Nakayama N, Ueno K.. Protective effects of goldenseal (Hydrastis canadensis L.) on acetaminophen-induced hepatotoxicity through inhibition of CYP2E1 in rats. Pharmacognosy Res 2011; 3: 250–5. [CrossRef] [PubMed] [Google Scholar]
  22. Du K, Williams CD, McGill MR, Xie Y, Farhood A, Vinken M, et al. The gap junction inhibitor 2-aminoethoxy-diphenyl-borate protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes and c-jun N-terminal kinase activation. Toxicol Appl Pharmacol 2013; 273: 484–91. [PubMed] [Google Scholar]
  23. Fouad AA, Jresat I. Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity. Environ Toxicol Pharmacol 2012; 33: 158–67. [PubMed] [Google Scholar]
  24. Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012; 3: 56. [CrossRef] [PubMed] [Google Scholar]
  25. Seki E, Brenner DA, Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 2012; 143: 307–20. [CrossRef] [PubMed] [Google Scholar]
  26. Benias PC, Gopal K, Bodenheimer H, Theise ND. Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis C. Clin Res Hepatol Gastroenterol 2012; 36: 44854. [Google Scholar]
  27. Iimuro Y, Fujimoto J. TLRs, NF-κB, JNK, and liver regeneration. Gastroenterol Res Pract 2010; 2010: 598109. [Google Scholar]
  28. Djafarzadeh S, Vuda M, Takala J, Ochs M, Jakob SM. Toll-like receptor-3-induced mitochondrial dysfunction in cultured human hepatocytes. Mitochondrion 2011; 11: 83–8. [PubMed] [Google Scholar]
  29. Zheng Z, Sheng Y, Lu B, Ji L. The therapeutic detoxification of chlorogenic acid against acetaminophen-induced liver injury by ameliorating hepatic inflammation. Chem Biol Interact 2015; 238: 93–101. [PubMed] [Google Scholar]
  30. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet 2011; 50: 349–69. [CrossRef] [PubMed] [Google Scholar]